Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.86
-0.02 (-0.23%)
Feb 19, 2026, 2:22 PM EST - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $154.83 million as of February 19, 2026. Its market cap has increased by 44.18% in one year.
Market Cap
154.83M
Enterprise Value
149.28M
1-Year Change
44.18%
Ranking
Category
Stock Price
$8.86
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $154.83M, a decrease of -50.41%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 155.18M | 11.56% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 157.14M |
| Rani Therapeutics Holdings | 155.55M |
| Adagene | 155.06M |
| Kalaris Therapeutics | 154.58M |
| Fate Therapeutics | 154.57M |
| Zentalis Pharmaceuticals | 152.81M |
| ProQR Therapeutics | 152.75M |
| Acumen Pharmaceuticals | 148.40M |